v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 139,590 $ 105,525
Restricted cash 72,839 93,409
Loans receivable at fair value 2,736,750 2,874,092
Capitalized software and other intangibles, net 66,934 71,698
Right of use assets - operating 11,206 9,441
Other assets 101,993 103,691
Total assets 3,129,312 3,257,856
Liabilities    
Secured financing 304,159 199,384
Asset-backed notes at fair value 137,778 263,799
Asset-backed borrowings at amortized cost 2,088,453 2,192,649
Corporate financing 119,891 143,663
Lease liabilities 12,003 11,468
Other liabilities 59,895 56,811
Total liabilities 2,722,179 2,867,774
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at June 30, 2026 and December 31, 2025; 46,222,056 shares issued and 45,950,033 shares outstanding at June 30, 2026; 44,709,065 shares issued and 44,437,042 shares outstanding at December 31, 2025 8 8
Common stock, additional paid-in capital 629,838 623,668
Accumulated deficit (216,404) (227,285)
Treasury stock at cost, 272,023 shares at June 30, 2026 and December 31, 2025 (6,309) (6,309)
Total stockholders’ equity 407,133 390,082
Total liabilities and stockholders' equity $ 3,129,312 $ 3,257,856

Source

HTML PDF
XBRL
ZIP